Publicaciones en colaboración con investigadores/as de Karolinska University Hospital (9)

2021

  1. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

    International Journal of Geriatric Psychiatry, Vol. 36, Núm. 2, pp. 324-333

  2. Hypercholesterolemia and 27-Hydroxycholesterol Increase S100A8 and RAGE Expression in the Brain: a Link Between Cholesterol, Alarmins, and Neurodegeneration

    Molecular Neurobiology, Vol. 58, Núm. 12, pp. 6063-6076

2018

  1. Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1546-1556

2017

  1. Emerging clinical issues and multivariate analyses in PET investigations

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 386-404

  2. Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 3, (353-357), 10.1007/s00259-016-3589-9)

    European Journal of Nuclear Medicine and Molecular Imaging

  3. The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis

    European Journal of Nuclear Medicine and Molecular Imaging

2015

  1. A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives

    European Journal of Nuclear Medicine and Molecular Imaging

2013

  1. Appropriate use criteria for amyloid PET imaging cannot replace guidelines: On behalf of the European Association of Nuclear Medicine

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 7, pp. 1122-1125

  2. Is It Possible to Improve Memory Function by Upregulation of the Cholesterol 24S-Hydroxylase (CYP46A1) in the Brain?

    PLoS ONE, Vol. 8, Núm. 7